ClinPhone Invests in IT Infrastructure to Make Customer Clinical Trial Data Ultra Secure
ClinPhone, the global leader in clinical trial management solutions, is embarking on a 9 month project to overhaul its IT subsystems in order to make its customers' data even more secure and reliable. By investing in a state-of-the-art storage and backup software platform from IBM, and by building a completely new data center to supplement its existing one, ClinPhone will have more flexibility and capacity to manage clinical trials data for its growing customer base and worldwide operations.
To date, ClinPhone's solutions have been deployed in over 1100 trials across 80 countries and in 71 languages, with 331 current live trials. The robustness of the company's IT systems is paramount to ensure a stable and high quality service to its global customers in the biotech and pharmaceutical industries. This investment in key infrastructure will reduce risk and allow ClinPhone to strengthen its business continuity plans and capabilities.
"Our current infrastructure already handles in excess of 100,000 transactions per month and as this is set to grow quite considerably, we are implementing new systems that will not only make our operations more robust, but will also give us more capacity and a completely scaleable solution. We will be able to quadruple the amount of data we currently process", explains Daljit Cheema, IT director, ClinPhone.
Daljit continues: "It means that the data that we collect and process on behalf of our clients will be safer, more efficient, and continue to be available 24/7. This venture is not just about implementing technology, it is also about people and procedures. We already have stringent procedures in place with uninterrupted on-call support. Our new IT platform will ultimately make our operation more flexible and secure, and our new second data center will further strengthen our systems against any downtime as the volume of clinical transactions grows in line with increased sponsor demand for our services."
ClinPhone's new data center will benefit from fibre-optic connections. This will make the flow of information risk-free and will satisfy prevailing guidelines. Moreover, in an industry that is highly regulated, this new IT infrastructure will satisfy client and regulatory audits.
Standardizing on the IBM enterprise platform for storage (San Volume Controller - SVC) and backup (Tivoli), ClinPhone's ability and capacity to handle its customers' complex clinical trials data will be further enhanced. As the company adds new technology solutions to its portfolio, such as patient diaries and patient recruitment solutions, this investment in a future-proof infrastructure is all the more important.
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Caliper Creates Specialized ACES Team to Deliver Customized Technology Solutions - Initiative to Deliver Best-In-Class Solutions for Laboratory Automation
From eResearchTechnology to ERT - The Philadelphia-based company unveils its dynamic new identity and commits to ‘Getting It Done, Right’.
Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure in Heart Failure - 45 patients enrolled in study designed to evaluate the ability of cardiopoietic cells to restore cardiac function
Genentech And Ipsen Agree To Develop Sustained-Release Formulations Of Recombinant Human Growth Hormone
Amorfix Life Sciences' test detects scrapie prions in bllod ofg scrapie-infected sheep
Infinity and MedImmune Announce Promising Biological Activity of Anti-Hsp90 Compound in Phase I GIST Trial
